RetroVascular's Acquisition

RetroVascular was acquired by Asahi Intecc on July 12, 2018.

RetroVascular is developing cardiological tools for percutaneous transluminal coronary angioplasty procedures, specifically to treat chronic total occlusions.…

Articles about RetroVascular's Acquisition: